PAR 2.50% 19.5¢ paradigm biopharmaceuticals limited..

An IL-8 Investigation, page-5

  1. 4,356 Posts.
    lightbulb Created with Sketch. 6907
    Hi Hamman,


    No is the short answer.

    Certainly another inflammatory condition that iPPS could potentially address.

    Inflammatory Bowel Disease (IBD) is the overarching condition under which diseases such as Chron's disease falls. There is definitely some real chance that iPPS can address Chron's disease which I've come across in the past thus by extrapolation, IBD being another inflammatory condition also should be a possible future indication for us.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.